Clinical Trials Logo

Ventilation, Mechanical clinical trials

View clinical trials related to Ventilation, Mechanical.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05410262 Completed - Clinical trials for Ventilation, Mechanical

Specific Mechanical Power Assessment in Patients With Acute Respiratory Distress Syndrome

Start date: July 1, 2022
Phase:
Study type: Observational [Patient Registry]

In ARDS patients, mechanical ventilation should minimize ventilator-induced lung injury. The mechanical power which is the energy per unit time released to the respiratory system according to the applied tidal volume, PEEP, respiratory rate, and flow should reflect the ventilator-induced lung injury

NCT ID: NCT01095276 Completed - Atelectasis Clinical Trials

Impact of Nebulized Dornase Alpha on Mechanically Ventilated Patients

Start date: November 2005
Phase: N/A
Study type: Interventional

The investigators hypothesized that dornase alpha, administered twice a day (BID) by in-line nebulizer, would improve oxygenation, compliance, and time to extubation in adult patients receiving mechanical ventilation.

NCT ID: NCT00927745 Completed - Clinical trials for Ventilation, Mechanical

Clinical Evaluation of AutoFlow Mode During Mechanical Ventilation

AFON
Start date: December 2002
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the long term use of AutoFlow mode during mechanical ventilation in ICU patients

NCT ID: NCT00893672 Completed - Clinical trials for Intensive Care Units

Comparison of Two Chest Radiograph Prescription Strategies in Intensive Care Unit

RARE
Start date: December 2006
Phase: N/A
Study type: Observational

Current guidelines recommend Routine daily chest radiographs (CXRs) for mechanically ventilated patients in intensive care units (ICUs). However, some ICUs have shifted to an On-demand strategy, in which this CXR is only prescribed if warranted by the patient's status at the morning physical examination. Here the investigators compared Routine and On-demand strategies in 21 French ICUs. The working hypothesis was that CXR prescriptions would fall by at least 20% with the On-demand strategy, with no reduction in quality of care.